Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128(a)(1) — Felony Conviction · Date: 10/20/2024 · State: NY
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
537
Total Claims
$270K
Drug Cost
126
Beneficiaries
$2,143
Cost/Patient
Risk Score Breakdown 20/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+438%
Cost per patient vs peers
$2,143 vs $399 avg
🔎 Data Overview
This provider appears on the federal OIG exclusion list, meaning they have been formally barred from participating in federal healthcare programs due to fraud, patient abuse, licensing issues, or other misconduct. The fact that they still appear in active prescribing data is a significant concern.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Brand vs Generic
Brand: 0 claims · $0
Generic: 423 claims · $116K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tirzepatide | 35 | $36K |
| Diclofenac Sodium | 23 | $12K |
| Lidocaine | 16 | $3,262 |
| Gabapentin | 44 | $616 |
| Tizanidine Hcl | 53 | $575 |
| Trazodone Hcl | 24 | $428 |
| Cyclobenzaprine Hcl | 16 | $232 |
| Topiramate | 15 | $187 |
| Baclofen | 15 | $186 |
| Duloxetine Hcl | 13 | $149 |
| Quetiapine Fumarate | 14 | $130 |
| Methylprednisolone | 15 | $128 |
| Meloxicam | 22 | $93 |
Prescribing Profile
Patient Profile
67
Avg Age
64%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data